ClinicalTrials.gov
public full text
Public Domain
A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma
This study explores if a composite biomarker strategy predicts exacerbation risk in patients with asthma on high dose inhaled corticosteroid (+/-long-acting beta agonist) treatment and to evaluate the utility of this composite score to facilitate personalised biomarker specific titration of corticosteroid therapy in this population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists#1230732
- Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma#854642
- Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management#889192
- Inflammatory Profiling in Chronic Lung Disease#238232
- Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma#862464
Record · ID 1183933
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive